![]() | Shih‐Wei WangGraduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan | Department of Medicine, MacKay Medical College, New Taipei ... |
KOL Resume for Shih‐Wei Wang
Year | |
---|---|
2021 | Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan |
2020 | Department of Medicine, MacKay Medical College, New Taipei City 25242, Taiwan;, Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan |
2019 | Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital. Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, Kaohsiung. Graduate Institute of Natural Products, College of Pharmacy Kaohsiung Medical University, Kaohsiung, 807, Taiwan |
2018 | Department of Medicine, Mackay Medical College, Taipei, Taiwan, View further author information Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan;, (S.-R.C.);, (S.-W.W.);, (C.-J.S.);, (H.-C.H.);, (Y.-L.Y.) |
2017 | Department of Medicine, Mackay Medical College, New Taipei City 25160, Taiwan;, |
2016 | Department of Medicine, Mackay Medical College, New Taipei City 25245, Taiwan. |
2015 | ††Department of Medicine, Mackay Medical College, New Taipei City, Taiwan. From the School of Pharmacy, Master Program in Clinical Pharmacy (S-WW, Y-BH, C-YC); Department of Pharmacy (Y-BH, C-YC); Department of Surgery, Division of Cardiovascular surgery (J-WH, C-CC); and Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan (W-TL). Mackay Medical College Department of Medicine New Taipei City Taiwan |
2014 | Department of Medicine, Mackay Medical College, New Taipei City 252, Taiwan, |
2012 | Department of Medicine, Mackay Medical College, New Taipei City, Taiwan, ROC |
2011 | Department of Medicine, Mackay Medical College, New Taipei City, Taiwan, Republic of China |
2009 | Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan |
2008 | Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan. |
2007 | Pharmacological Institute, College of Medicine, National Taiwan University, No. 1, Jen-Ai Road, Sect. 1, Taipei, Taiwan |
2006 | Pharmacological Institute, College of Medicine, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei, Taiwan |
2004 | Pharmacological Institutes, College of Medicine, National Taiwan University, 1 Jen-Ai Road, Sect. 1, Taipei, Taiwan. |
Shih‐Wei Wang: Influence Statistics
Concept | World rank |
---|---|
hydroxyzoanthenamine 5 | #1 |
ear sponges | #1 |
angiogenesis endothelial | #1 |
tumoursecreted bfgf | #1 |
sepsis mapk | #1 |
carbonylcarbene | #1 |
4aaqb mapk | #1 |
nmr drg | #1 |
vegfr2 vorinostat | #1 |
chondrosarcoma cells angiogenesis | #1 |
raw2647 taiwan | #1 |
zoanthamine alkaloid derivatives | #1 |
affect cell growth | #1 |
buffer nicotine | #1 |
angiogenesis epcs | #1 |
epcs compounds | #1 |
sorafenib tumour progression | #1 |
isolated zoantharian | #1 |
p53mutated cells paca2 | #1 |
hydroxyzoanthenamine | #1 |
hydroxykuroshine | #1 |
mmp9 vecadherin vimentin | #1 |
phenylurea histone deacetylase | #1 |
30hydroxykuroshine 8 | #1 |
detection ellagic | #1 |
demonstrated butein | #1 |
88 μm ascomycota | #1 |
indigenous medicinal mushroom | #1 |
cytotoxic effects butein | #1 |
30hydroxyzoanthenamine | #1 |
zoantharian zoanthus antimetastatic | #1 |
vivo effects butein | #1 |
lpssimulated raw2647 cells | #1 |
surface tβrii | #1 |
bfgf epcs | #1 |
pseurotins compounds | #1 |
antimetastatic nmr | #1 |
30hydroxykuroshine | #1 |
hydroxy28 deoxyzoanthenamine | #1 |
aggressive malignancy chemotherapy | #1 |
arf1 mmp9 | #1 |
7αhydroxy28deoxyzoanthenamine 3αhydroxyzoanthenamine | #1 |
Open the FULL List in Excel | |
Prominent publications by Shih‐Wei Wang
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment
[ PUBLICATION ]
Chemokines modulate angiogenesis and metastasis that dictate cancer development in tumor microenvironment. Osteosarcoma is the most frequent bone tumor and is characterized by a high metastatic potential. Chemokine CCL5 (previously called RANTES) has been reported to facilitate tumor progression and metastasis. However, the crosstalk between chemokine CCL5 and vascular endothelial growth factor (VEGF) as well as tumor angiogenesis in human osteosarcoma microenvironment has not been well ...
Known for Human Osteosarcoma | Endothelial Growth | Ccl5 Ccr5 | Messenger Rna | Tumor Angiogenesis |
CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells
[ PUBLICATION ]
Chondrosarcoma is the second most common primary malignant bone cancer, with potential for local invasion and distant metastasis. Chemokine CCL5 (formerly RANTES) of the CC-chemokine family plays a crucial role in metastasis. Angiogenesis is essential for the cancer metastasis. However, correlation of CCL5 with vascular endothelial growth factor (VEGF) expression and angiogenesis in human chondrosarcoma is still unknown. CCL5-mediated VEGF expression was assessed by qPCR, ELISA, and ...
Known for Chondrosarcoma Cells | Vegf Expression | Signaling Pathway | Chemokine Ccl5 | Endothelial Progenitor |
CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression
[ PUBLICATION ]
Connective tissue growth factor (CTGF, a.k.a. CCN2) is inflammatory mediator and abundantly expressed in osteoarthritis (OA). Angiogenesis is essential for OA progression. Here, we investigated the role of CTGF in vascular endothelial growth factor (VEGF) production and angiogenesis in OA synovial fibroblasts (OASFs). We showed that expression of CTGF and VEGF in synovial fluid were higher in OA patients than in controls. Directly applying CTGF to OASFs increased VEGF production then ...
Known for Growth Factor | Synovial Fibroblasts | Vascular Endothelial | Dependent Angiogenesis | Vegf Expression |
Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway
[ PUBLICATION ]
Chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and cause distant metastasis. Adiponectin is a protein hormone secreted predominantly by differentiated adipocytes. On the other hand, angiogenesis is a critical step in tumor growth and metastasis. However, the relationship of adiponectin with vascular endothelial growth factor-A (VEGF-A) expression and angiogenesis in human chondrosarcoma is mostly unknown. In this study we first demonstrated ...
Known for Human Chondrosarcoma | Inbred Balb Mice | Tumor Growth | Vegfa Expression | Factor Vegf |
Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells
[ PUBLICATION ]
Chondrosarcoma is the second most common sarcoma in bone malignancy and is characterized by a high metastatic potential. Angiogenesis is essential for the cancer metastasis. Endothelin-1 (ET-1) has been implicated in tumor angiogenesis and metastasis. However, the relationship of ET-1 with vascular endothelial growth factor (VEGF) expression and angiogenesis in human chondrosarcoma cells is mostly unknown. Here, we found that the expression of ET-1 and VEGF were correlated with tumor ...
Known for Human Chondrosarcoma Cells | Endothelial Growth | Vegf Expression | Nude Neovascularization | Tumor Angiogenesis |
This study delineates the antiproliferative activities and in vivo efficacy of YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] in human hepatocellular carcinoma cells. YC-1 inhibited the growth of HA22T and Hep3B cells in a concentration-dependent manner without significant cytotoxicity. YC-1 induced G(1) phase arrest in the cell cycle, as detected by an increase in the proportion of cells in the G(1) phase using FAC-Scan flow cytometric analysis. It was further shown that cGMP, ...
Known for Cell Cycle | Tumor Growth | G1 Phase | Yc1 Expression | Benzyl Indazole |
Angiogenesis is the formation of new capillaries from preexisting vasculature. The perpetuation of angiogenesis plays a critical role in the pathogenesis of various disease states including rheumatoid arthritis (RA). Cysteine-rich 61 (Cyr61 or CCN1) is an important proinflammatory cytokine in RA. Here, we investigated the role of CCN1 in angiogenesis associated with vascular endothelial growth factor (VEGF) production and osteoblasts. We found higher expression of CCN1 and VEGF in ...
Known for Vegf Production | Experimental Arthritis | Ccn1 Expression | Endothelial Progenitor Cells | Synovial Fluid |
Chondrosarcomas are a type of primary malignant bone cancer, with a potent capacity for local invasion and distant metastasis. Brain-derived neurotrophic factor (BDNF) is commonly upregulated during neurogenesis. The aim of the present study was to examine the mechanism involved in BDNF-mediated vascular endothelial growth factor (VEGF) expression and angiogenesis in human chondrosarcoma cells. Here, we knocked down BDNF expression in chondrosarcoma cells and assessed their capacity to ...
Known for Human Chondrosarcoma | Growth Factor | Derived Neurotrophic | Vascular Endothelial | Vegf Expression |
CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells
[ PUBLICATION ]
Osteosarcoma is the most frequent bone tumor, characterized by a high metastatic potential. However, the crosstalk between chemokine (C-C motif) ligand 3 (CCL3), which facilitates tumor progression and metastasis. Vascular endothelial growth factor-A (VEGF-A), an angiogenesis inducer and a highly specific mitogen for endothelial cells, has not been well explored in human osteosarcoma. Here we demonstrate the correlation of CCL3 and VEGF-A expressions, quantified by immunohistochemistry, ...
Known for Osteosarcoma Cells | Vegfa Expression | Inbred Balb Mice | Jnk Erk | Human Endothelial |
Chondrosarcoma, a common malignant tumour, develops in bone. Effective adjuvant therapy remains inadequate for treatment, meaning poor prognosis. It is imperative to explore novel remedies. Angiogenesis is a rate-limiting step in progression that explains neovessel formation for blood supply in the tumour microenvironment. Numerous studies indicate that EPCs (endothelial progenitor cells) promote angiogenesis and contribute to tumour growth. bFGF (basic fibroblast growth factor), a ...
Known for Growth Factor | Chondrosarcoma Cells | Vegf Expression | Endothelial Progenitor | Basic Fibroblast |
Chondrosarcoma is a primary malignant bone cancer, with a potent capacity to invade locally and cause distant metastasis. Angiogenesis is a critical step in tumor growth and metastasis. Chemokine CCL5 (previously called RANTES) has been shown to facilitate tumor progression and metastasis. However, the relationship of CCL5 with vascular endothelial growth factor (VEGF) expression and angiogenesis in human chondrosarcoma is mostly unknown. In this study, CCL5 increased VEGF expression and ...
Known for Chondrosarcoma Cells | Endothelial Growth | Vegf Expression | Tumor Angiogenesis | Chemokine Ccl5 |
Osteosarcoma is characterized by a high malignant and metastatic potential. Angiogenesis is essential for the caner metastasis. Interleukin-6 (IL-6) is a multifunctional cytokine that is associated with the disease status and outcomes of cancers. However, the relationship between IL-6 and vascular endothelial growth factor (VEGF) expression in human osteosarcoma is mostly unknown. Here we found that the IL-6 and VEGF expression was correlated with tumor stage and significantly higher ...
Known for Vegf Expression | Growth Factor | Vascular Endothelial | Osteosarcoma Cells | Map Kinase |
Endothelial progenitor cells (EPCs) promote angiogenesis and are therefore key contributors to a wide variety of angiogenesis-related autoimmune diseases such as rheumatoid arthritis (RA). However, the signaling mechanisms through which these progenitor cells influence RA pathogenesis remain unknown. The aim of this study was to examine whether resistin plays a role in the pathogenesis of and angiogenesis associated with RA by circulating EPCs. We found that levels of resistin in ...
Known for Rheumatoid Arthritis | Progenitor Cells | Expression Resistin | Epcs Angiogenesis | Synovial Fluid |
WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma
[ PUBLICATION ]
In recent years, much research has focused on the role of angiogenesis in osteosarcoma, which occurs predominantly in adolescents and young adults. The vascular endothelial growth factor-A (VEGF-A) pathway is the key regulator of angiogenesis and in osteosarcoma. VEGF-A expression has been recognized as a prognostic marker in angiogenesis. Aberrant WNT1-inducible signaling pathway protein-1 (WISP-1) expression is associated with various cancers. However, the function of WISP-1 in ...
Known for Human Osteosarcoma | Vegfa Expression | Endothelial Cells | Tube Formation | Signaling Proteins |
Arthritis is a process of chronic inflammation that results in joint damage. IL (interleukin)-1β is an inflammatory cytokine that acts as a key mediator of cartilage degradation, and is abundantly expressed in arthritis. Neovascularization is one of the pathological characteristics of arthritis. However, the role of IL-1β in the angiogenesis of chondrocytes remains unknown. In the present study, we demonstrate that stimulating chondrocytes (ATDC5) with IL-1β increased the expression of ...
Known for Growth Factor | Endothelial Progenitor | 2 Expression | Cell Angiogenesis | Interleukin1β Il1β |
Key People For Human Chondrosarcoma Cells
Shih‐Wei Wang:Expert Impact
Concepts for whichShih‐Wei Wanghas direct influence:Human chondrosarcoma cells, Chondrosarcoma cells, Human chondrosarcoma, Vegf expression, Endothelial progenitor cells, Tanshinone iia, Endothelial progenitor, Growth factor.
Shih‐Wei Wang:KOL impact
Concepts related to the work of other authors for whichfor which Shih‐Wei Wang has influence:Cancer cells, Cell proliferation, Growth factor, Rheumatoid arthritis, Signaling pathway, Mesenchymal stem, Tumor angiogenesis.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |